139 related articles for article (PubMed ID: 16398215)
41. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
42. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter.
Werner H; Bach MA; Stannard B; Roberts CT; LeRoith D
Mol Endocrinol; 1992 Oct; 6(10):1545-58. PubMed ID: 1448110
[TBL] [Abstract][Full Text] [Related]
43. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.
Bindra RS; Glazer PM
Oncogene; 2007 Mar; 26(14):2048-57. PubMed ID: 17001309
[TBL] [Abstract][Full Text] [Related]
44. Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Infante M; Durán M; Marcos G; Lastra E; Gómez-Barrero S; Velasco EA
Breast Cancer Res Treat; 2018 Aug; 171(1):53-63. PubMed ID: 29766361
[TBL] [Abstract][Full Text] [Related]
45. Cloning and analysis of rat osteoclast inhibitory lectin gene promoter.
Quan JX; Zheng F; Li XX; Hu LL; Sun ZY; Jiao YL; Wang BL
J Cell Biochem; 2009 Mar; 106(4):599-607. PubMed ID: 19127542
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F.
Weir L; Chen D
Gene Expr; 1996; 6(1):45-57. PubMed ID: 8931991
[TBL] [Abstract][Full Text] [Related]
47. Single nucleotide polymorphisms in the human corticosteroid-binding globulin promoter alter transcriptional activity.
Li Y; Wu L; Lei J; Zhu C; Wang H; Yu X; Lin H
Sci China Life Sci; 2012 Aug; 55(8):699-708. PubMed ID: 22932886
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of ubiquitous expression of mouse uncoupling protein 2 mRNA: control by cis-acting DNA element in 5'-flanking region.
Yoshitomi H; Yamazaki K; Tanaka I
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):397-404. PubMed ID: 10333481
[TBL] [Abstract][Full Text] [Related]
49. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
[TBL] [Abstract][Full Text] [Related]
50. Regulation of a promoter of the fibroblast growth factor 1 gene in prostate and breast cancer cells.
Payson RA; Chotani MA; Chiu IM
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):93-103. PubMed ID: 9719443
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the 5'-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies.
Nabokina SM; Said HM
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G822-9. PubMed ID: 15217784
[TBL] [Abstract][Full Text] [Related]
52. Cloning and characterization of murine p53 upstream sequences reveals additional positive transcriptional regulatory elements.
Reisman D; Eaton E; McMillin D; Doudican NA; Boggs K
Gene; 2001 Aug; 274(1-2):129-37. PubMed ID: 11675005
[TBL] [Abstract][Full Text] [Related]
53. Sequence analysis of the human glycoprotein hormone alpha-subunit gene 5'-flanking DNA and identification of a potential regulatory element as an alu repetitive sequence.
Scofield MA; Xiong W; Haas MJ; Zeng Y; Cox GS
Biochim Biophys Acta; 2000 Oct; 1493(3):302-18. PubMed ID: 11018255
[TBL] [Abstract][Full Text] [Related]
54. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
55. Association between polymorphisms of the DNA repair gene RAD51 and ovarian cancer.
Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Romanowicz H; Wilczak M
Pol J Pathol; 2013 Dec; 64(4):290-5. PubMed ID: 24375044
[TBL] [Abstract][Full Text] [Related]
56. Regulation of transcription of the murine gamma-glutamyl hydrolase gene. Delineation of core promoter A and the role of LYF-1, E2F and ETS-1 in determining tumor-specific expression.
Masumoto N; Chen J; Sirotnak FM
Gene; 2002 May; 291(1-2):169-76. PubMed ID: 12095690
[TBL] [Abstract][Full Text] [Related]
57. Glial fibrillary acidic protein transcriptional regulation is independent of a TFIID-binding downstream initiator sequence.
Hatch N; Sarid J
J Neurochem; 1994 Dec; 63(6):2003-9. PubMed ID: 7964717
[TBL] [Abstract][Full Text] [Related]
58. Single nucleotide polymorphisms 5' upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage.
Kinslow CJ; El-Zein RA; Hill CE; Wickliffe JK; Abdel-Rahman SZ
Genes Chromosomes Cancer; 2008 Nov; 47(11):923-32. PubMed ID: 18651651
[TBL] [Abstract][Full Text] [Related]
59. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.
Dong Y; Asch HL; Ying A; Asch BB
Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462
[TBL] [Abstract][Full Text] [Related]
60. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
